Summary. In children undergoing tonsillectomy, dexamethasone is recommended to reduce the risk of postoperative nausea and vomiting while non-steroidal anti-inflammatory drugs (NSAIDs) are used for pain relief. We aimed to determine whether children who receive dexamethasone or dexamethasone with NSAID are more likely to experience haemorrhage post-tonsillectomy. Randomized and non-randomized studies in which children undergoing tonsillectomy received dexamethasone or dexamethasone and NSAID were sought within bibliographic databases and selected tertiary sources. The risk of bias assessment and evaluation of haemorrhage rate data collection and reporting were assessed using the Cochrane Risk of Bias Tool and McHarm tool. Synthesis methods comprised pooled estimate of the effect of dexamethasone on the risk of haemorrhage rate using the Peto odds ratio (OR) method. The pooled estimate for haemorrhage rate in children who received dexamethasone was 6.2%, OR 1.41 (95% confidence interval 0.89-2.25, P¼0.15). There was risk of bias and inconsistent data collection and reporting rates of haemorrhage in many of the included studies. Clinical heterogeneity was observed between studies. The pooled analysis did not demonstrate a statistically significant increase in the risk of post-tonsillectomy haemorrhage with dexamethasone with/without NSAID use in children. However, the majority of the included studies were not designed to investigate this endpoint, and thus large studies which are specifically designed to collect data on haemorrhage rate are needed.
† They found no influence of these drugs on posttonsillectomy haemorrhage, but noted that further prospective research is needed.
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Keywords: dexamethasone; paediatrics; tonsillectomy Children who undergo tonsillectomy or adenotonsillectomy are at risk of experiencing complications. These include postoperative nausea and vomiting (PONV) and postoperative haemorrhage. In studies where intraoperative anti-emetics were not administered, post-tonsillectomy nausea and vomiting rates as large as 70% have been reported. 1 Post-tonsillectomy haemorrhage rates range from 0.1% to 8.1%. 2 The Association of Paediatric Anaesthetists of Great Britain and Ireland (APA) guideline on the prevention of postoperative vomiting (POV) recommends the use of dexamethasone (0.15 mg kg 21 in combination with ondansetron 0.05 mg kg 21 ) to minimize the risk of POV in children undergoing tonsillectomy. 3 A Cochrane review of dexamethasone use in tonsillectomy supports this recommendation; children receiving a single intraoperative dose of dexamethasone at a dose between 0.15 and 1 mg kg 21 were half as likely to vomit within 24 h of their operation. 4 Similarly, a systematic review and meta-have also addressed this issue: (i) using 14 randomized controlled trials (RCTs) of adults and children who underwent tonsillectomy, no difference in bleeding rates was demonstrated between dexamethasone and comparator arms (RR 1.02, 95% CI 0.65 -1.61, P¼0.92); 8 (ii) using 12 out of 23 studies that reported data on haemorrhage rates, 9 again no significant difference in postoperative bleeding was identified in children receiving single-dose dexamethasone vs placebo (OR 1.07, 95% CI 0.58 -1.98, P¼0.82); and (iii) using data from 29 RCTs of adult and paediatric tonsillectomy patients, 10 a pooled effects estimate again revealed no significant difference in postoperative haemorrhage in patients who had received dexamethasone vs those who had not (OR 0.96, 95% CI 0.66 -1.40, P¼0.83). This review aims to determine whether the use of dexamethasone or dexamethasone with NSAIDs in paediatric tonsillectomy affects the rate of post-tonsillectomy haemorrhage in children. There are limitations to the use of standard systematic review methodology in the evaluation of adverse event outcomes. This is particularly true of post-tonsillectomy haemorrhage because it is a rare adverse event and therefore haemorrhage rate data derived from small RCTs of dexamethasone may not be generalizable. It has been recommended that systematic reviews of rare adverse effects should include nonrandomized studies (NRS) which may cover a broader population than RCTs and in which the adverse event may be the primary outcome. 11 12 It is possible that haemorrhage rate data for dexamethasone used in this context may be unpublished (publication bias) or that it may have been selectively unreported due to undesirable outcome results (outcome reporting bias). 13 In order to address some of the limitations of standard systematic review methodology in the evaluation of a rare adverse event outcome, we included both RCTs and NRS and furthermore assessed the methodological quality of haemorrhage rate recording and reporting.
Methods

Search strategy
Search strategies were developed specifically for each database (the search strategy for MEDLINE is presented in Supplementary Table S1 ; details of similar strategies for the other databases can be provided from the authors upon request). The databases and tertiary sources used in this review are listed in Supplementary Table S2 . Searches were carried out in November 2011. The reference lists of previous systematic reviews, identified during the search, were also examined for additional references. After the selection of studies via this process, forward and backward citation tracking was undertaken for each study if it was indexed in the Scopus database. Contact was made with experts to identify other potentially relevant published and unpublished studies.
Study eligibility
RCTs and quasi-RCTs (q-RCTs) that considered dexamethasone (except by peri-tonsillar infiltration) or, dexamethasone in combination with NSAIDs, in the context of paediatric tonsillectomy or adenotonsillectomy in the immediate perioperative period were included (note: for the remainder of this report, the term tonsillectomy will be used to encompass both tonsillectomy and adenotonsillectomy). The immediate perioperative period was defined as: within the 24 h before the procedure, during the procedure, or in the 24 h which followed the procedure. This review considered only children up to the age of 18 yr; studies that included both adults and children were also considered, and, if possible, only the data for children were used. Studies were only considered for inclusion if they were published in English.
Types of outcome measure
The main outcome of interest extracted from each study was haemorrhage rate. The definition of haemorrhage included any bleeding which required a change in postoperative management, for example, re-operation, blood transfusion, prolonged hospital stay, re-admission, or contact with a healthcare provider, for example, an accident and emergency department or a general practitioner. In some studies where participants may have experienced more than one haemorrhage, we recorded the number of haemorrhages rather than the number of patients who experienced a haemorrhage. This is because we considered recurrent bleeding to be a clinically important outcome in postoperative patients.
Study selection
Inspection of citations
After duplicate citations were removed, all titles and abstracts were independently reviewed by two reviewers (J.R.B., J.J.K.) with reference to the inclusion/exclusion criteria (Supplementary Table S3 ), and a decision was made whether to retrieve the full report of the study. The number of titles/abstracts identified, accepted, and rejected was recorded.
Inspection of retrieved reports
Once the full reports were retrieved, they were inspected for relevance to the review and the inclusion and exclusion criteria applied. Studies not meeting the predetermined criteria were excluded. If there was any disagreement about whether to include any of the studies, a third reviewer (A.J.N.) assessed them and, together with the other reviewers, made a consensus decision about whether to include or exclude. A record was made of the number of papers retrieved and the number of papers excluded. For quality assurance purposes, 5% of studies excluded at title and abstract stage were re-reviewed (J.R.B., J.J.K.) for inclusion and five studies excluded at the full article stage were re-reviewed by M.P. or A.J.N.
Data collection
A formal data extraction form was designed, piloted independently on a small selection of studies, and adjusted as necessary. For each study, information regarding methods, participants, comparison groups, interventions, and outcomes was tabulated. Where they were recorded or provided by the author, the following data were extracted for each randomized study: Where it was recorded or provided by the author, the following data were extracted for each non-randomized study: 
Quality assessment
For RCTs that compared dexamethasone with another intervention and reported haemorrhage rate or for which haemorrhage rate data were obtained from the author(s), the methodological quality was assessed using the Cochrane Collaboration's domain-based evaluation tool for assessing risk of bias. 14 The methodological quality of haemorrhage rate recording and reporting was assessed for both randomized and NRS using selected elements of the McMaster Quality Assessment Scale of Harms for primary studies (the McHarm Scale), http://hiru.mcmaster.ca/epc/mcharm.pdf. The elements used were selected based on an evaluation of their relevance to our research question and they aimed to evaluate: the quality and appropriateness of study design and reporting, the applicability of the study findings to the population, and measures taken to reduce bias (Supplementary Table S4 ). 15 Both data collection and quality assessment of studies were undertaken by one reviewer (J.R.B.), with three randomized and three NRS assessed by a second reviewer (J.J.K.) to check for consistency.
Statistical analysis and synthesis
Statistical analyses were performed using RevMan (version 5.1 software). As haemorrhage rate data are dichotomous, the data were analysed by calculating the Peto OR for each randomized study and for NRS, ORs were calculated with the corresponding 95% CIs. For each study, we only included data for participants who were not excluded after randomization and for whom follow-up was complete.
Meta-analysis
We aimed to conduct two meta-analyses. For RCTs, dexamethasone alone was compared with any other intervention used in paediatric tonsillectomy. For NRS, dexamethasone alone was compared with any other intervention used in paediatric tonsillectomy.
Heterogeneity and subgroups
If clinical heterogeneity was too great, studies were not pooled in a meta-analysis and narrative synthesis was used to compare studies. A x 2 test for statistical heterogeneity was undertaken, and the I 2 statistic was calculated. Where the necessary data were available, the following subgroup analysis was also planned: † a comparison of primary and secondary haemorrhage rates; † a comparison of studies in which some participants received NSAIDs in addition to dexamethasone with those in which no participants received NSAIDs.
Studies in which all participants received dexamethasone For RCTs: † report the haemorrhage rate for each arm of the trial.
For NRS: † report the haemorrhage rate for each study.
Publication bias
Publication bias for the randomized trials included in the meta-analysis was assessed by visual inspection of a funnel plot. All study authors were contacted where possible for missing outcome data.
Results
Search results
The database searches undertaken in November 2011 identified 3419 abstracts for screening after duplicate records were removed. After review of abstracts, 139 full-text articles were reviewed. Of these, 52 unique studies (37 RCTs and 15 NRS) fulfilled the inclusion criteria (Fig. 1 ). Forward and backward citation tracking for all the eligible articles in the database search, plus the reference sections of 15 review articles identified in our database search, identified 962 potentially relevant citations not identified in our initial searches. After review of abstracts, 880 articles were excluded, leaving 82 full articles to be reviewed. Of these, 10 additional articles (three RCTs and seven NRS) met the inclusion criteria (Fig. 2) . One article reported an RCT already identified in another article picked up by our database search. In total, 61 studies were included in this review (39 RCTs and 22 NRS). In the remaining seven randomized studies, all participants received dexamethasone, 6 47-52
Included studies
and of these, four did not report haemorrhage rate (588 participants). 6 Full-text articles could not be obtained (n=2) 84 85 Integrity of author questioned (n=1) 86 87 Combined data on children and adults (n=4) [88] [89] [90] [91] Ongoing trial (n=2) 82 83 Included articles (n=57 representing 52 studies, 37 RCT and 15 NRS) Records not found in our search (n=382)
Records after duplicates removed (n=490)
Records from backward citation tracking for the 15 reviews identified (n=684)
Records after duplicates removed (n=485)
Records not found in our search (n=323)
Records not found in our search (n=369)
Full text assessed for eligibility (n=82)
Records excluded (n=880)
Eligible articles (n=12 representing 12 studies)
Records excluded (n=67)
Could not obtain (n=1) 92 Full text non-English (n=1) 93 Incorrectly referenced (n=1) Eligibility Included Duplicates removed and titles and abstracts screened (n=962 )
Combined data on children and adults (n=2) 94 95 Eligible articles (n=10 representing 10 studies, 3 RCT and 7 NRS) Nine of the 22 NRS compared dexamethasone with another intervention. 53 -61 Of these, six studies involving 688 participants did not report haemorrhage rate. 53 55 -57 59 60 In the remaining 13, all participants received dexamethasone 62 -74 and of these, two did not report haemorrhage rate (258 participants). 64 70 Randomized studies which compared dexamethasone with another intervention and reported haemorrhage rate ; in one study, all children received 10 mg rather than a weight-based dose. 43 At least some of the participants of four of the studies 7 16 26 41 received NSAIDs. The primary outcome in the majority of studies was PONV, postoperative pain, or both. Haemorrhage rate and severity was the primary outcome in one study. 25 Four studies predefined haemorrhage 7 25 42 and seven reported additional information about the haemorrhages they detected. 7 7 25 and one used a standard checklist for haemorrhage rate data collection. 25 It was unclear whether there was a possibility of selective outcome reporting bias for five of these studies. 19 28 30 42 46 The overall haemorrhage rate for participants who received placebo ranged from 0% to 8.6% and the overall haemorrhage rate for participants who received dexamethasone ranged from 0% to 15.6%. The pooled estimate of haemorrhage rate for children who received dexamethasone was 6.2%. Of the 15 studies that reported data on haemorrhage rate, there was a non-significant increase in the risk of haemorrhage for the dexamethasone intervention group (Peto OR 1.41, 95% CI 0.89-2.25, P¼0.15) (Fig. 3) .
Fourteen out of 15 studies reporting data on haemorrhage separated the data into primary and secondary haemorrhage rates. For primary haemorrhage, only seven events were observed in the dexamethasone group and three on placebo; the pooled estimate demonstrated a non-significant increase in haemorrhage rate (Peto OR 1.42, 95% CI 0.38-5.36, P¼0.61; Fig. 4 ). For secondary haemorrhage, the pooled estimate again suggested that there was a non-significant increase in the risk of haemorrhage for the dexamethasone intervention group (Peto OR 1.42, 95% CI 0.86-2.35, P¼0.17; Fig. 4) .
In the four studies in which some children also received NSAIDs, the pooled estimate indicated that there was a nonsignificant increase in the risk of haemorrhage for the dexamethasone intervention group (Peto OR 1.56, 95% CI 0.69 -3.51, P¼0.28). For the eight studies in which no children received NSAIDs, again there was a non-significant increase in the risk of haemorrhage in the dexamethasone group (Peto OR 1.32, 95% CI 0.73-2.37, P¼0.36) (Fig. 5) .
A funnel plot of the studies included in our meta-analysis shows no evidence of publication bias (Fig. 6) .
Randomized studies in which all participants received dexamethasone and reported haemorrhage rate (Table 3) . One study predefined haemorrhage, 47 and another actively collected haemorrhage rate data and specifying the timing and frequency of haemorrhage rate data collection. 49 The haemorrhage rates in two of these studies ranged from 0% to 2%. The rate was unclear in one of these studies.
49
NRS which compared dexamethasone with another intervention and reported haemorrhage rate
There were 2088 participants in these three studies 54 58 61 published between 1999 and 2011. They were all retrospective case note reviews and two of them retrieved 2 week follow-up data. In one of the studies, a single method of tonsil dissection was used, 61 while in the other studies, there were several methods recorded. 54 58 In the retrospective chart review conducted by Conley and Ellison, 54 children who received dexamethasone were operated on using a standard surgical technique-cold-knife dissection and snare and haemostasis was achieved using tonsillar packs dipped in bismuth subgallate-phenylephrine hydrochloride mixture followed by suction electrocautery and a 3 min observation period. However, children who did not receive dexamethasone were operated on using either cold-knife dissection, snare, and suction electrocautery or electrocautery dissection; tonsillar packs were not used in any of these children. The dexamethasone doses administered in these three studies ranged from 0.04 to 0.62 mg kg 21 . The report of one study specifies that dexamethasone was administered or withheld according to the anaesthetist's preference. 61 NSAIDs were administered 
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to some of the participants in one study. 58 The primary outcome was haemorrhage rate for all of these studies. Two of these studies predefined haemorrhage 54 61 and all reported their haemorrhages in detail, providing information on the need for and types of re-intervention ( Table 4 ). All of these studies predefined haemorrhage, but none actively collected data on haemorrhage rate. None of these studies used a standard checklist for haemorrhage rate data collection and for all of them, it was unclear whether there was a possibility of selective outcome reporting bias. The haemorrhage rates for participants who did and did not receive dexamethasone ranged from 1.1% to 8.3% and 3.8% to 9.7%, respectively (Fig. 7) .
NRS in which all participants received dexamethasone and reported haemorrhage rate These 11 studies included 6200 participants, 62 63 65 -69 71 -74 and were published between 2002 and 2011. They comprise five retrospective chart reviews, 63 65 67 -69 three prospective observational studies, 66 73 74 two audits, 71 72 and a retrospective analysis of data from an RCT. 62 The period of follow-up in these studies ranged from 6 h to 30 days and seven reported the technique used to remove the tonsils. 63 (Table 5) . Two of the studies predefined haemorrhage, 65 69 one undertook passive haemorrhage rate data collection, 65 the timing and frequency of haemorrhage rate data collection was specified by two authors, 67 72 and there was a possibility of selective outcome reporting in two studies. 68 73 The haemorrhage rate in these 11 studies ranged from 0.4% to 5.7%.
Discussion
Summary of findings
Data from the 15 RCTs included in our meta-analysis and the three NRS in which dexamethasone was compared with another intervention indicate that the overall risk of posttonsillectomy haemorrhage in children is not significantly increased by the perioperative use of dexamethasone.
Limitations of included studies
The overall risk of bias was high or unclear for all of the included RCTs. Among both the randomized studies and NRS, there was clinical heterogeneity. Some of the elements of study design that have an impact on haemorrhage risk are: dissection technique, haemostasis technique, 75 patient age, gender, and the indication for surgery 65 76 and the perioperative use of NSAIDs. 77 Our evaluation of haemorrhage rate data collection and reporting indicates that this was inadequately reported in the majority of studies. Many studies did not follow children beyond the point at which primary outcomes would be measured. Studies which relied on re-admission as a method of haemorrhage detection may have missed minor self-limiting bleeds or bleeds attended to at other healthcare facilities. Studies which used patient and parent questionnaires to detect bleeding episodes may have missed haemorrhages due to questionnaires being incomplete or unreturned. Very few studies described active surveillance for adverse outcomes; for example, a telephone call or face-to-face contact whereby participants were specifically asked about any haemorrhages experienced.
Comparison with results of previous studies
In our meta-analysis of 15 RCTs, the pooled estimate risk ratio for haemorrhage in children who received dexamethasone was 1.41 (95% CI 0.89-2.25, P¼0.15; I 2 ¼13%). The interpretation of our finding conforms to that of three previous meta-analyses of randomized studies, although the difference in the summary statistic reflects differences in study identification and inclusion. Geva and Brigger 8 calculated a relative risk of haemorrhage of 1.02 (95% CI 0.65 -1.61, P¼0.92) for adult and paediatric patients in their meta-analysis who received dexamethasone. The haemorrhage rate among those who received dexamethasone was 5.9%. Their analysis included 14 studies, nine of which were also included in our analysis; of the five that were not included in our analysis, three included adult participants only, one was in Hebrew, and for one, we were not able to obtain sufficient detail from the author about the participants who experienced a haemorrhage. A meta-analysis of studies involving only children calculated an OR of haemorrhage for children who had received dexamethasone compared with those who did not (OR¼1.07; 95% CI 0.58 -1.98, P¼0.82). 9 Their analysis included 12 studies; of which, 10 were the same as those in our review. The two studies we did not include were those where we could not obtain a haemorrhage rate from the authors. The haemorrhage rate for children who received dexamethasone in this study was 6.2%. Finally, the most recent meta-analysis calculated an OR of 0.96 (95% CI 0.66 -1.40, I 2 ¼0%). 10 This review included 29 studies of systemic steroid use in tonsillectomy and haemorrhage rate in adults and children. The haemorrhage rate for patients who received systemic steroids was 4.6%. We included 13 of these 29 plus an additional study The following reported zero primary haemorrhages in both intervention groups: Volk (1993) , Ohlms (1995) , April (1996) , Pappas (1998) , Nawasreh (2000) , Giannoni (2002) , Hanasono (2004) , Malde (2005) , Kaan (2006) , Catlin (2006) , Alajmi (2008) The following reported zero secondary haemorrhages in both intervention groups: Pappas (1998) , Kaan (2006) Fig 4 Subgroup analysis: primary and secondary haemorrhage rates.
they did not identify 46 and another where the results were published more recently. 25 Of the 16 studies, we did not include:
five were not in English, six involved adults only, for three we could not obtain data on haemorrhage rate, one reported combined data on adults and children, and in one the intervention was prednisolone rather than dexamethasone.
Data not included in previous reviews
We included two RCTs not included by previous systematic reviews. One of these studies was identified in both the EMBASE and MEDLINE. Although it did not report haemorrhage rate, we obtained the necessary data from the author. 46 The results of the second randomized study by Gallagher and colleagues were published after the previous reviews. This was the only randomized study included here which had the rate and severity of post-tonsillectomy haemorrhage as its primary outcome measure. 25 The study was a non-inferiority study (onesided test). Non-inferiority was tested for haemorrhage events in each of three groups (levels I-III, see footnote to Table 1 for definitions) rather than grouping all haemorrhage events together. The hypothesis was that dexamethasone would not increase haemorrhage rate by more than 5% (rather than that there would be no difference between the two groups). Noninferiority was not shown for level I bleeding events, but it was demonstrated for both level II and level II bleeding events. Unsurprisingly, the assessments of risk of bias and methodological quality show that the risk of bias for this study is generally low, and overall, the methodology for haemorrhage rate detection and reporting was the most robust. Consequently, the haemorrhage rate in this study is at the upper end of the range for our Kaan (2006) For the following it was unclear whether NSAIDs had been administered: Nawasreh (2000) randomized studies (9.6%). We calculated the overall relative risk of haemorrhage with dexamethasone administration in this study and found a non-significant increase in risk: 1.32 (95% CI 0.58-3.07, P¼0.5653). The categorization of haemorrhages by severity level was one strength of this study; this was undertaken by only six of our included randomized studies. When haemorrhages are categorized in such a way, the results become useful to clinicians and policy-makers. In Gallagher and colleagues' study, although there were a total of 30 haemorrhages, 18 did not require any change in postoperative care and only four required re-operation. The evaluation of haemorrhage rate data from NRS was not conducted in previous reviews. Our evaluation of three studies provides conflicting results. The data for two of these studies indicated that children in the control group were more likely to experience a haemorrhage than those who received dexamethasone. 54 58 In one of these studies, there were too many differences in the way the two intervention groups were managed to draw any meaningful conclusions about the effects of dexamethasone administration on haemorrhage risk. 54 In a third study, there was no difference between the intervention groups, but dexamethasone had been administered according to anaesthetist preference (no further details available), and it is therefore possible that children with an increased risk of haemorrhage were not administered dexamethasone. 61 All three studies were retrospective chart reviews using hospital records. Although they report haemorrhage rates which correspond to those quoted in the literature, 2 there is some evidence that retrospective chart review underestimates haemorrhage rate. 78 
Conclusions
We did not find any evidence that dexamethasone statistically or clinically significantly increases the risk of post-tonsillectomy haemorrhage. However, the degree of imprecision in our pooled estimate of the OR (upper bounds of the 95% CI were 2.25) prevents us from ruling out a clinically relevant doubling in risk. There were insufficient data to determine any additional impact of NSAID use, an issue which is likely to gain greater prominence, given the recent moves away from the use of codeine as an analgesic in children after tonsillectomy. In the studies included here, we detected inadequacies in haemorrhage rate detection and reporting. Further large studies (both randomized and observational) are needed to provide evidence about the safety of dexamethasone+NSAIDs in paediatric tonsillectomy. For instance, a 2×2 factorial trial would be an elegant method of addressing both dexamethasone and NSAID use, individually and in combination. The findings of four ongoing trials will provide additional data on outcomes for the use of dexamethasone 79 80 and ibuprofen 81 82 in paediatric tonsillectomy. Future research studies need to have haemorrhage rate as their primary outcome with a consensus group of clinicians, caregivers, and patients agreeing beforehand on predefined levels of severity that can be used in research worldwide. Table 3 Randomized studies in which all participants received dexamethasone and in which haemorrhage rate was reported. Dex, dexamethasone; NSAID, non-steroidal anti-inflammatory drug; Robust methodologies need to be developed with strategies to prospectively and actively capture data on haemorrhage outcomes for all participants over an adequate follow-up period. To achieve this, multicentre prospective real-world posttonsillectomy registries (similar in nature to databases that record outcomes after percutaneous coronary intervention) should be set-up to collect important baseline variables such as dose/timing of analgesics, type of surgery, etc., so that risk factors for haemorrhage and serious adverse events can be evaluated. 
